Navigation Links
Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
Date:12/20/2007

BETHESDA, Md., Dec. 20 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBS and NWBT), Northwest Biotherapeutics ("NWBT") announced today that Lonza Group AG has withdrawn all claims of patent infringement involving NWBT's DCVax(R)-Brain product and other NWBT DCVax(R) products other than DCVax(R)-Prostate. Lonza had alleged that NWBT's DCVax(R) cancer vaccine products infringed certain gene expression technology patents held by Lonza. However, as could be seen from publicly available information sources -- available before the Lonza lawsuit was filed as well as since then -- NWBT does not use any gene modification or gene expression system in its DCVax(R) products.

Lonza filed suit against NWBT on July 27, 2007, in the U.S. District Court for the District of Delaware, alleging that all of NWBT's DCVax(R) products infringed certain gene expression patents held by Lonza. After the filing of a lawsuit, a period of up to 120 days is allowed for service of the complaint on the party sued. In this case, Lonza chose not to serve NWBT throughout the entire 120-day period. As a result, the filing of an answer and counterclaims by NWBT was delayed until this extended period had expired. During the 120-day period, NWBT provided further information to Lonza -- in addition to the already publicly available information sources -- showing that NWBT's DCVax(R) products do not use any gene expression system. When Lonza still chose not to withdraw its complaint, NWBT filed an answer and counterclaims as soon as the 120-day period expired, denying all infringement claims by Lonza, and seeking recovery for violation of the Delaware Deceptive Trade Practices Act, unfair competition, tortious interference with prospective contractual relations, and abuse of process, including, among other things, treble damages and punitive damages. Following NWBT's filing of this answer and counterclaim, Lonza agreed with NWBT to the dismissal of
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
2. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
3. Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements
4. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
5. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
6. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
7. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
8. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
9. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
10. Pressure BioSciences, Inc. Issued First Patent in Canada
11. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, ... distribution agreement with VWR to distribute TECTA™ B16, ... than 160 years of experience, VWR, a leading ... and production facilities, has cultivated a value proposition ... to enable science. Endetec’s TECTA™ B16, combines ...
(Date:5/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/qfxkcq/global_cell ) has ... Market Outlook 2020 " report to their offering. ... regenerative medicine is expected to have huge marketing potential. ... in the growth of deregulated organs. Several therapeutic molecules ... to form new tissue or sometimes organ transplant is ...
(Date:5/20/2015)... 2015  Marc Tessier-Lavigne, president of The Rockefeller ... million from The Marie-Josée and Henry R. Kravis ... that will be the centerpiece of the University,s ... R. Kravis Research Building, two stories high, will ... three city blocks following the shoreline of the ...
(Date:5/20/2015)... , 20. Mai 2015 /PRNewswire/ ... klinische Logistik (Clinical Logistics Organization/CLO) hat ... 2014, das am 31. Dezember 2014 ... hat die Marktentwicklung übertroffen und sein ... http://photos.prnewswire.com/prnh/20110930/NY78064LOGO ...
Breaking Biology Technology:Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 2The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 4Marken schließt Ergebnisse für das Geschäftsjahr 2014 ab 2
... 8, 2011 Quest Diagnostics joined the American Cancer ... the American Cancer Society,s historic Cancer Prevention Study - ... longitudinal study is between November 8 and 19, 2011. ... and genetic factors that influence cancer risk by following ...
... 2011 Accuray Incorporated (Nasdaq: ARAY), the ... results for the first quarter of fiscal 2012 that ... 2011, Accuray completed the acquisition of TomoTherapy. As a ... consolidation of both Accuray and TomoTherapy.  Non-GAAP results are ...
... YORK, Nov. 8, 2011 Reportlinker.com announces ... available in its catalogue: ... Suppliers http://www.reportlinker.com/p0681961/Genomic-Technologies-Market-Insights-for-Life-Science-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics ... Genomic Technologies: Market Insights for Life Science ...
Cached Biology Technology:Quest Diagnostics Encourages Denver Area Residents to Enroll in Historic American Cancer Society Prevention Study November 8th - 19th 2Quest Diagnostics Encourages Denver Area Residents to Enroll in Historic American Cancer Society Prevention Study November 8th - 19th 3Accuray Announces Results for First Quarter Fiscal 2012 2Accuray Announces Results for First Quarter Fiscal 2012 3Accuray Announces Results for First Quarter Fiscal 2012 4Accuray Announces Results for First Quarter Fiscal 2012 5Accuray Announces Results for First Quarter Fiscal 2012 6Accuray Announces Results for First Quarter Fiscal 2012 7Accuray Announces Results for First Quarter Fiscal 2012 8Accuray Announces Results for First Quarter Fiscal 2012 9Accuray Announces Results for First Quarter Fiscal 2012 10Accuray Announces Results for First Quarter Fiscal 2012 11Genomic Technologies: Market Insights for Life Science Suppliers 2Genomic Technologies: Market Insights for Life Science Suppliers 3
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, ... control and security systems is pleased to announce that ... as a consultant and member of its scientific advisory ... widely known as a thought leader in technology-enhanced learning ... Technology Group, and has published studies and books focused ...
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... young scientists have received postdoctoral fellowships from the National ... they conduct research with the eventual aim of protecting ... mentorship from a faculty member at their home institution, ... research teams. This allows them to interact with some ...
... from a pivotal, large-scale Phase III trial, published online ... , show that the RTS,S malaria vaccine candidate can ... immunization with a control vaccine, infants (aged 6-12 weeks ... episodes of both clinical and severe malaria and had ...
... Nearly 3,000 insect scientists are expected to attend Entomology 2012, ... this November in Knoxville, TN. Members of the media who ... press pass. WHEN: November 11-14, 2012 ... WHAT: Entomology 2012 is the 60th Annual ...
Cached Biology News:Space research institute awards postdoctoral fellowships to 4 scientists 2RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants 2RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants 3RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants 4
... post-translational modification that plays an important ... regulation, inflammation, cell-to-cell adhesion, and cell ... lectin based Glycoprotein Isolation Kits, Concanavalin ... (WGA), that allow isolation of glycoproteins ...
... powerful yet simple technology for labeling peptides, ... provides the heterobifunctional linkers SFB and SANH ... It enables conjugation of various tags including ... a variety of proteins. , ...
... series of laser scanners is the starting ... solution. ,Gene expression analysis, SNP (Single ... essential to the advancement of research in ... novel microarray formats and sizes. These arrays ...
... The Lumat tube luminometer provides the sensitivity ... purpose luminometer. Advanced digital photon counting with ... match of spectral demands. Equipped with up ... ideally suited for reporter gene assays as ...
Biology Products: